Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients
NCT06409819Phase 2Recruiting
- Sponsor
- University of California, San Diego
- Start
- Jun 2025
- Primary completion
- Oct 2026
- Modality
- Oncolytic Viruses
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in urinary tract infection (UTI) comparing Phage Therapy with Placebo (2 arms). Primary endpoints: Number of participants with treatment-related adverse events at 180 days, Enrollment Feasibility at 180 days and 2 more. Started Jun 2025; status: recruiting.
02
Drugs
bacteriophages
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT06409819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06409819.